C1: ‘We shall find.’

The C1 single-cell sequencer from Fluidigm revolutionised the field of life science research by enabling researchers to explore tumour heterogeneity to better understand, among other things, cancer pathologies and mechanisms — and how new treatment designs could stop them. One of the methods scientists use to do this is called single-cell mRNA sequencing, and the […]

Fluidigm: Take Aim

A leader in life science technology, Fluidigm designs, manufacturers and distributes laboratory machines that enable researchers to look deeper into biological and genetic mutations, to better understand and treat disease. This ad campaign was designed for the immuno-oncology sector and highlighted the ability of Fluidigm’s C1 system to identify single cells within a larger cell […]